Surgery for colorectal liver metastases: The impact of resection margins on recurrence and overall survival

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Angelsen, Jon Helge ^a,b   Horn, Arild ^a   Eide, Geir E ^a,b   Viste, Asgaut ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Colorectal liver metastases; Local recurrence; Overall survival; Preoperative chemotherapy; Resection margin; Time to recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PREOPERATIVE CARE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; ADULT; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84901244438     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-127     Document Type: Article

References (39)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318. 10.1097/00000658-199909000-00004, 1420876, 10493478.
2. Adam R, de Haas RJ, Wicherts DA, Vibert E, Salloum C, Azoulay D, Castaing D. Concomitant extrahepatic disease in patients with colorectal liver metastases when is there a place for surgery?. Ann Surg 2011, 253:349-359. 10.1097/SLA.0b013e318207bf2c, 21178761.
3. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis an international multi-institutional analysis of 1669 patients. Ann Surg 2009, 250:440-448.
4. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S. Determinants of survivla in liver resection for colorectal secondaries. Br J Surg 1986, 73:727-731. 10.1002/bjs.1800730917, 3756436.
5. Cady B, Jenkins RL, Steele GD, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998, 227:566-571. 10.1097/00000658-199804000-00019, 1191314, 9563547.
6. Elias D, Cavalcanti A, Sabourin JC, Lassau N, Pignon JP, Ducreux M, Coyle C, Lasser P. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998, 24:174-179. 10.1016/S0748-7983(98)92878-5, 9630855.
7. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997, 84:1077-1080. 10.1002/bjs.1800840810, 9278644.
8. Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 2010, 17:1324-1329. 10.1245/s10434-009-0770-4, 19847565.
9. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005, 241:715-724. 10.1097/01.sla.0000160703.75808.7d, 1357126, 15849507.
10. Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB 2010, 12:43-49. 2814403, 20495644.
11. Hamady ZZR, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JPA. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol 2006, 32:557-563. 10.1016/j.ejso.2006.02.001, 16580811.
12. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma - minimum surgical margins for successful resection. Arch Surg 2002, 137:833-840.
13. Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 2008, 143:384-393. 10.1016/j.surg.2007.09.038, 18291260.
14. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases is it still a contraindication to surgery?. Ann Surg 2008, 248:626-636.
15. Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol 2011, 37:336-343. 10.1016/j.ejso.2011.01.007, 21277151.
16. Ayez N, Lalmahomed ZS, Eggermont AMM, Ijzermans JNM, de Jonge J, van Montfort K, Verhoef C. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the Era of neoadjuvant chemotherapy. Ann Surg Oncol 2012, 19:1618-1627. 10.1245/s10434-011-2114-4, 3332355, 22006375.
17. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247. 10.1016/j.ejca.2008.10.026, 19097774.
18. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Euan TW, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371:1007-1016. 10.1016/S0140-6736(08)60455-9, 2277487, 18358928.
19. Punt CJA, Buyse M, Kohne C-H, Hohenberger P, Labianca R, Schmoll HJ, Pahlman L, Sobrero A, Douillard JY. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007, 99:998-1003. 10.1093/jnci/djm024, 17596575.
20. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
22. Cox DR. Regression models and life-tables. J Royal Stat Soc B Stat Methodol 1972, 34:187-220.
23. Royston P, Sauerbrei W. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Stat Med 2004, 23:2509-2525. 10.1002/sim.1815, 15287081.
24. Altendorf-Hofmann ASJ. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 2003, 12:165-192. 10.1016/S1055-3207(02)00091-1, 12735137.
25. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002, 235:759-765. 10.1097/00000658-200206000-00002, 1422504, 12035031.
26. Tsim N, Healey AJ, Frampton AE, Habib NA, Bansi DS, Wasan H, Cleator SJ, Stebbing J, Lowdell CP, Jackson JE, Tait P, Jiao LR. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol 2011, 18:1939-1946. 10.1245/s10434-010-1533-y, 21298352.
27. Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, Codina-Barreras A, Mojal S. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 2007, 18:1190-1195. 10.1093/annonc/mdm106, 17434896.
28. Vandeweyer D, Neo EL, Chen JWC, Maddern GJ, Wilson TG, Padbury RTA. Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB 2009, 11:499-504. 10.1111/j.1477-2574.2009.00092.x, 2756637, 19816614.
29. Hamady ZZ, Lodge JP, Welsh FK, Toogood GJ, White A, John T, Rees M. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg 2014, 259:543-548. 10.1097/SLA.0b013e3182902b6e, 23732261.
30. Konopke R, Kersting S, Makowiec F, Gassmann P, Kuhlisch E, Senninger N, Hopt U, Saeger HD. Resection of colorectal liver metastases: is a resection margin of 3 mm enough?. World J Surg 2008, 32:2047-2056. 10.1007/s00268-008-9629-2, 18521661.
31. Wray CJ, Lowy AM, Mathews JB, Park S, Choe KA, Hanto DW, James LE, Soldano DA, Ahmad SA. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 2005, 12:374-380. 10.1245/ASO.2005.06.038, 15915371.
32. Hayashi H, Nabeshima K, Hamasaki M, Yamashita Y, Shirakusa T, Iwasaki H. Presence of microsatellite lesions with colorectal liver metastases correlate with intrahepatic recurrence after surgical resection. Oncol Rep 2009, 21:601-607.
33. Holdhoff M, Schmidt K, Diehl F, Aggrawal N, Angenendt P, Romans K, Edelstein DL, Torbenson M, Kinzler KW, Vogelstein B, Choti MA, Diaz LA. Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res 2011, 17:3551-3557. 10.1158/1078-0432.CCR-10-3087, 3282919, 21531819.
34. Ng JKS, Urbanski SJ, Mangat N, McKay A, Sutherland FR, Dixon E, Dowden S, Ernst S, Bathe OF. Colorectal liver metastases contract centripetally with a response to chemotherapy - a histomorphologic study. Cancer 2008, 112:362-371. 10.1002/cncr.23184, 18041069.
35. Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 2007, 246:295-300. 10.1097/SLA.0b013e31811ea962, 1933562, 17667509.
36. Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 2013, 257:1079-1088. 10.1097/SLA.0b013e318283a4d1, 23426338.
37. Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, de Gramont A, Tiret E, Paye F. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy. World J Surg 2013, 37:2647-2654. 10.1007/s00268-013-2186-3, 23982776.
38. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990, 322:352-358. 10.1056/NEJM199002083220602, 2300087.
39. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004, 350:2343-2351. 10.1056/NEJMoa032709, 15175436.